IAP
Indie Asset Partners Portfolio holdings
AUM
$55M
This Quarter Return
+10.08%
1 Year Return
+12.03%
3 Year Return
+98.02%
5 Year Return
+179.46%
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(+12%)
Cap. Flow
+$3.52M
Cap. Flow
% of AUM
2.56%
Top 10 Holdings %
Top 10 Hldgs %
56.56%
Holding
136
New
10
Increased
38
Reduced
54
Closed
10
Top Buys
| 1 |
Royalty Pharma
RPRX
|
$4.17M |
| 2 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
$2.69M |
| 3 |
Global X Blockchain ETF
BKCH
|
$687K |
| 4 |
Service Corp International
SCI
|
$504K |
| 5 |
Lam Research
LRCX
|
$424K |
Top Sells
| 1 |
Microsoft
MSFT
|
$1.1M |
| 2 |
Exxon Mobil
XOM
|
$729K |
| 3 |
Apple
AAPL
|
$508K |
| 4 |
SPDR S&P 600 Small Cap Value ETF
SLYV
|
$330K |
| 5 |
CRISPR Therapeutics
CRSP
|
$326K |
Sector Composition
| 1 | Healthcare | 42.37% |
| 2 | Technology | 12.48% |
| 3 | Consumer Discretionary | 4.69% |
| 4 | Industrials | 3.41% |
| 5 | Communication Services | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
126
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $63K | 0.05% |
24,500
+1,000
| +4% | +$2.57K |
|
|
127
CRISPR Therapeutics
CRSP
$4.71B
| – | – |
-2,915
| Closed | -$326K |
|
128
Chevron
CVX
$324B
| – | – |
-2,171
| Closed | -$220K |
|
129
Gain Therapeutics
GANX
$71.5M
| – | – |
-29,652
| Closed | -$221K |
|
|
HIVE
130
HIVE Digital Technologies
HIVE
$677M
| – | – |
-11,000
| Closed | -$29K |
|
131
IBM
IBM
$227B
| – | – |
-1,498
| Closed | -$208K |
|
132
OrthoPediatrics
KIDS
$536M
| – | – |
-3,232
| Closed | -$212K |
|
133
Lyft
LYFT
$6.73B
| – | – |
-4,164
| Closed | -$223K |
|
134
MiMedx Group
MDXG
$1.05B
| – | – |
-11,200
| Closed | -$68K |
|
135
McCormick & Company Non-Voting
MKC
$18.9B
| – | – |
-2,612
| Closed | -$212K |
|
136
Teladoc Health
TDOC
$1.37B
| – | – |
-2,414
| Closed | -$306K |
|